Allogeneic Stem Cell Transplantation: Clinical Trials

1 trial for Allogeneic Stem Cell Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1

Follow Allogeneic Stem Cell Transplantation: new trials by email Literature Review of Allogeneic Stem Cell Transplantation trials Research Report on Allogeneic Stem Cell Transplantation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
IFN-γ (interferon gamma-1b) injection - Myelodysplastic Syndromes, Myeloid Leukemia
Early Phase 1CompletedSawa Ito, MD82021-03-082025-04-29

Narrower conditions

Graft vs Host Disease (1)  ·  Leukemia, Myeloid (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)

Broader conditions

Bone Marrow Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Leukemia (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Injections (1)  ·  interferon gamma-1b (1)

Sponsors

Sawa Ito, MD (1)

Countries

United States (1)

Top investigators

Sawa Ito, MD; PhD (1)